Union Cycliste Internationale
English  |  Français  
News ▪
Home Road Track Mountain Bike Cyclo-cross BMX Trials Indoor cycling Para-cycling Cycling for all
Agrandir le texte Réduire le texte Imprimer la page Envoyer l'article


Anti-doping: modifications to No Needle Policy




At its meeting in Louisville (USA) at the beginning of the month, the UCI Management Committee approved a change to the UCI No Needle Policy, forbidding an athlete to compete within eight days of receiving a local injection of glucocorticosteroids.

The UCI must be informed by the doctor applying such an injection. The No Needle Policy, introduced by the UCI to its Medical Regulations in 2011, originally stipulated that a rider must not compete for 48 hours after a local injection of glucocorticosteroids.

“I requested the UCI Medical Commission to consider an extension of this period,” explains UCI President Mr Pat McQuaid. “A rider who raced at the weekend could receive an injection of glucocorticosteroids and be racing again in a mid-week competition. Glucocorticosteroids are used to treat inflammations, so a rider requiring this treatment should not be racing within eight days. He or she should be attending his/her condition and resting.”

The regulations apply to all licensed riders and at all times.

The UCI Management Committee also approved another modification to the UCI No Needle Policy, stating that athletes no longer need to report injections for vaccination purposes, for example for the flu.


UCI Communication Services

  Publications  Links  Employment  FAQ  Contacts  RSS